Nephrogenic Fibrosing Dermopathy (NFD) Lawsuits No Longer Reviewed
Nephrogenic Fibrosing Dermopathy (NFD) is a progressive disorder which has been shown to occur in those with chronic kidney problems or impaired renal function. It is associated with fibrosis, or scarring, which results in thick, coarse and hard skin around the joints, which can severely restrict movements.
The condition was first identified in 1997, and first reported in medical literature in 2000. While initial reports describe the condition as Nephrogenic Fibrosing Dermopathy (NFD), as additional information has been discovered about the disorder, the name has changed to Nephrogenic Systemic Fibrosis (NSF).
NSF/NFD has been directly linked to the use of gadolinium based contrast agents given before MRI and MRA tests. Nephrogenic Fibrosing Dermopathy lawsuits are being reviewed nationwide against the manufacturers of gadolinium based contrast agents.
The development of NSF/NFD has been directly linked to gadolinium contrast agents which are often given before MRI (magnetic resonance imaging) or MRA (magnetic resonance angiography) to differentiate blood vessels from other tissue on the films. About five percent of those with kidney failure, renal disease or other kidney problems develop the painful and disabling condition.
The term “Nephrogenic Fibrosing Dermopathy” is often used interchangeably with “Nephrogenic Systemic Fibrosis”. However, research has found that the disorder is systemic, involving fibrosis of other organs, as opposed to just the skin.
Nephrogenic refers to the disorders origins in the kidney or being caused by factors originating in the kidney.
Fibrosing or Fibrosis indicates that the disorder increases interstitial fibrous tissue, or scarring
Dermopathy indicates that it is a disease of the skin
Systemic more accurately refers to the characteristis that the disorder affects the body generally, as oppose to only effecting the skin.
>>INFORMATION: Nephrogenic Systemic Fibrosis
There have been over 400 confirmed cases of Nephrogenic Fibrosing Dermopathy/Nephrogenic Systemic Fibrosis worldwide, but most experts expect that number to increase signficantly as physicians become more aware of the condition.
>>INFORMATION: NFD Information
NEPHROGENIC FIBROSING DERMOPATHY CLAIMS NO LONGER REVIEWED
The Nephrogenic Fibrosing Dermopathy lawyers at Saiontz & Kirk, P.A. previously pursued lawsuits for those who have suffered from this disorder as a result of this MRI/MRA contrast. New claims are no longer being investigated. This page is provided for informational purposes only.